NCT04936399 2022-05-25A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United KingdomBristol-Myers SquibbCompleted87 enrolled